Riboxin Avexima, 200 mg 50 pcs

Riboxin is a derivative (nucleoside) of purine, a precursor of adenosine phosphate ATP. It belongs to the group of drugs that stimulate metabolic processes.

Indications

Active ingredient

Interaction

Directions for use

Riboxin is administered orally before meals.

The daily dose of the drug when taken orally is 0.6-2.4 g.

In the first days of treatment the daily dose is 0.6-0.8 g (200 mg 3-4 times a day).

In case of good tolerance the dose is increased on the 2nd or 3rd day up to 1.2 g (0.4 g 3 times a day), if necessary – up to 2.4 g a day.

The duration of treatment is from 4 weeks to 1.5-3 months.

In case of urocoproporphyria the daily dose is 0.8 g (200 mg 4 times a day). The course of treatment is 1-3 months.

Special Instructions

Contraindications

Side effects

Similarities